Recent work
Chris is a partner in our Corporate and M&A group, based in Hong Kong. He specialises in high-value, cross-border M&A and strategic transactions across the Asia-Pacific region, with particular expertise in multi-jurisdictional structuring, regulatory complexity and stakeholder alignment.
Chris has a focus on financial institutions and insurance, including bancassurance, alongside a broader practice advising corporates and sponsors across sectors such as technology and infrastructure.
He has advised on a number of landmark transactions, including Hang Seng on its privatisation by HSBC that valued Hang Seng at US$37.2 billion, S.F. Holding on its US$2.3 billion acquisition of a controlling stake in Kerry Logistics, and Arm on its US$34 billion sale to SoftBank.
His experience also includes advising Reckitt Benckiser on the US$2.2 billion carve-out of its China nutrition business, Arm on the establishment of its Arm China joint venture with HOPU, and SoftBank Vision Fund on investments in Ping An Good Doctor and Ping An Healthcare.
In the financial institutions and insurance space, Chris has advised on Southeast Asia’s largest insurance M&A (FWD on its US$3 billion acquisition of SCB Life and related bancassurance arrangements in Thailand), as well as on numerous complex M&A, bancassurance and capital markets transactions across Asia-Pacific including for Prudential, Aviva, Standard Chartered, Eastspring and Sumitomo Mitsui.
Chris is a CEDR Accredited Mediator, which informs his approach to complex negotiations and multi-party transactions.